GlobeNewswire

NTG Nordic Transport Group A/S – Launch of medium-term financial targets for 2029-2031
09/11/2026
Company announcement no. 46 – 26 09 November 2026 NTG Nordic Transport Group A/S – Launch of medium-term financial targets for 2029-2031 NTG Nordic Transport Group A/S (“NTG”) today launches medium-term financial [...]
Baylor Genetics to Highlight the Clinical Value of Genomics in Pediatric Care at the 2026 National Society of Genetic Counselors Annual Meeting
09/11/2026
Two new data presentations underscore the diagnostic and clinical utility of genome and exome sequencing for pediatric patients with hearing loss and immunodeficiency HOUSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Baylor [...]
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
09/11/2026
CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T [...]
Kraig Labs Ships Spider Silk to Developers Across Global Industries
09/11/2026
A Global Apparel Pilot and Shipment to a Materials Innovator with Aerospace Experience Put Customer Feedback in Focus DENVER, Nov. 09, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews )—Kraig Biocraft Laboratories ( OTCQB: KBLB [...]
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits
09/11/2026
Company announcement – No. 55 / 2026 Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 [...]
Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits
09/11/2026
SYNCHRONIZE-CVOT met its primary endpoint demonstrating the safety of survodutide in terms of major adverse cardiovascular events compared with placebo in people with obesity and established cardiovascular disease (CVD [...]
Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients
09/11/2026
Single-cell sequencing demonstrates pelareorep’s ability to remodel the tumor microenvironment in a hematological cancer SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics [...]
Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission
09/11/2026
Following FDA orphan drug designation in 2025, the European decision marks a further milestone as Oncovita prepares to initiate clinical development in late 2027 The European Commission granted orphan designation on [...]
USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows
09/11/2026
AZmed's FDA-cleared, clinically validated X-ray AI suite to be integrated into USARAD's workflows through Nanox Marketplace Expansion builds on USARAD's existing use of AZmed AI, from acute trauma to chest X-rays, to [...]
CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026
09/11/2026
-Data presented in a late-breaking oral presentation at AHA- -A single-course treatment with CTX310 produced a mean reduction from baseline of 65% in circulating ANGPTL3 and 63% in triglycerides (TG) at Day 30 in [...]
Park Dental Partners Completes Acquisition of Village Family Dental Support Services Organization, Expands into North Carolina
09/11/2026
MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) (the “Company”), a leading dental resource organization, announced that it completed its acquisition of the Village Family Dental [...]
Daré Bioscience Releases Next Episode in “CEO Corner” Video Series
09/11/2026
Sabrina Martucci Johnson, Founder, President and CEO, discusses numerous potential value drivers expected to power the Company’s next phase of growth and commercial success Access the CEO Corner here SAN DIEGO, Nov. 09 [...]
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
09/11/2026
SAN DIEGO, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]
OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap
09/11/2026
Contracted Demand Now Stands at Nearly 14 Times Full-Year 2025 Bookings, with Roughly Half of 2026 Contracts from New Customers MINNEAPOLIS, Nov. 09, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“ [...]
HealthEx is Among the First Consumer Health Apps to Support MyChart Central’s Community Authorization for Single-Login Access to Epic Records
09/11/2026
Individuals can now sign in once with their Epic ID to access and share records from their linked health systems and build a more complete health history in HealthEx Wallet SAN FRANCISCO, Nov. 09, 2026 (GLOBE NEWSWIRE [...]
NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market
09/11/2026
The financing led by international healthcare investors, alongside The Crushing T1 Foundation, reinforces confidence in NewcelX’s strategy and long-term potential ZURICH, Nov. 09, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. ( [...]
LifeStance Health Group Announces Pricing of Secondary Public Offering
09/11/2026
SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health [...]
Curia augmente sa capacité de fermentation à León, en Espagne
09/11/2026
Cet investissement de 5 millions d’euros renforcera les opérations de fermentation et de traitement en aval ALBANY, New York, 09 nov. 2026 (GLOBE NEWSWIRE) -- Curia Global Inc. (Curia), une organisation mondiale de [...]
Curia Expands Fermentation Capacity in León, Spain
09/11/2026
The 5-million-euro investment will strengthen fermentation and downstream processing operations ALBANY, N.Y., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Curia Global Inc. (Curia), a global contract research, development and [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum